Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 162 entries
Sorted by: Best Match Show Resources per page
Vertebral Column Resection for Kyphoscoliosis in a Patient with Ehlers-Danlos Syndrome: An Intraoperative Neurophysiological Monitoring Alert.

Cureus

Jahangiri FR, Al Eissa S, Sayegh S, Al Helal F, Al-Sharif SA, Annaim MM, Muhammad S, Aziz T.
PMID: 27766191
Cureus. 2016 Aug 31;8(8):e759. doi: 10.7759/cureus.759.

A 16-year-old male patient with Ehler-Danlos syndrome (EDS) and a back deformity since birth presented with severe kyphoscoliosis. The patient was neurologically intact but had respiratory and cardiac insufficiencies. A two-stage vertebral column resection (VCR) at T9-T10 with multiple...

Cite
Jahangiri FR, Al Eissa S, Sayegh S, et al. Vertebral Column Resection for Kyphoscoliosis in a Patient with Ehlers-Danlos Syndrome: An Intraoperative Neurophysiological Monitoring Alert. Cureus. 2016;8(8):e759doi: 10.7759/cureus.759.
Jahangiri, F. R., Al Eissa, S., Sayegh, S., Al Helal, F., Al-Sharif, S. A., Annaim, M. M., Muhammad, S., & Aziz, T. (2016). Vertebral Column Resection for Kyphoscoliosis in a Patient with Ehlers-Danlos Syndrome: An Intraoperative Neurophysiological Monitoring Alert. Cureus, 8(8), e759. https://doi.org/10.7759/cureus.759
Jahangiri, Faisal R, et al. "Vertebral Column Resection for Kyphoscoliosis in a Patient with Ehlers-Danlos Syndrome: An Intraoperative Neurophysiological Monitoring Alert." Cureus vol. 8,8 (2016): e759. doi: https://doi.org/10.7759/cureus.759
Jahangiri FR, Al Eissa S, Sayegh S, Al Helal F, Al-Sharif SA, Annaim MM, Muhammad S, Aziz T. Vertebral Column Resection for Kyphoscoliosis in a Patient with Ehlers-Danlos Syndrome: An Intraoperative Neurophysiological Monitoring Alert. Cureus. 2016 Aug 31;8(8):e759. doi: 10.7759/cureus.759. PMID: 27766191; PMCID: PMC5061493.
Copy Download .nbib Format: NLM
Bridging the digital disconnect: Exploring the views of professionals on using technology to promote young people's mental health.

School Psychology International

Clarke AM, Chambers D, Barry MM.
PMID: 29081558
Sch Psychol Int. 2017 Aug;38(4):380-397. doi: 10.1177/0143034317700937. Epub 2017 Apr 25.

The increasing role of online technologies in young people's lives has significant implications for professionals' engagement with technologies to promote youth mental health and well-being. However, relatively little is known about professionals' views on the role of technologies in...

Cite
Clarke AM, Chambers D, Barry MM. Bridging the digital disconnect: Exploring the views of professionals on using technology to promote young people's mental health. Sch Psychol Int. 2017;38(4):380-397doi: 10.1177/0143034317700937.
Clarke, A. M., Chambers, D., & Barry, M. M. (2017). Bridging the digital disconnect: Exploring the views of professionals on using technology to promote young people's mental health. School Psychology International, 38(4), 380-397. https://doi.org/10.1177/0143034317700937
Clarke, Aleisha M, et al. "Bridging the digital disconnect: Exploring the views of professionals on using technology to promote young people's mental health." School Psychology International vol. 38,4 (2017): 380-397. doi: https://doi.org/10.1177/0143034317700937
Clarke AM, Chambers D, Barry MM. Bridging the digital disconnect: Exploring the views of professionals on using technology to promote young people's mental health. Sch Psychol Int. 2017 Aug;38(4):380-397. doi: 10.1177/0143034317700937. Epub 2017 Apr 25. PMID: 29081558; PMCID: PMC5646430.
Copy Download .nbib Format: NLM
Nano-cellulose derived bioplastic biomaterial data for vehicle bio-bumper from banana peel waste biomass.

Data in brief

Sharif Hossain AB, Ibrahim NA, AlEissa MS.
PMID: 27331103
Data Brief. 2016 May 25;8:286-94. doi: 10.1016/j.dib.2016.05.029. eCollection 2016 Sep.

The innovative study was carried out to produce nano-cellulose based bioplastic biomaterials for vehicle use coming after bioprocess technology. The data show that nano-cellulose particle size was 20 nm and negligible water absorption was 0.03% in the bioplastic. Moreover,...

Cite
Sharif Hossain AB, Ibrahim NA, AlEissa MS. Nano-cellulose derived bioplastic biomaterial data for vehicle bio-bumper from banana peel waste biomass. Data Brief. 2016;8:286-94doi: 10.1016/j.dib.2016.05.029.
Sharif Hossain, A. B., Ibrahim, N. A., & AlEissa, M. S. (2016). Nano-cellulose derived bioplastic biomaterial data for vehicle bio-bumper from banana peel waste biomass. Data in brief, 8286-94. https://doi.org/10.1016/j.dib.2016.05.029
Sharif Hossain, A B M, et al. "Nano-cellulose derived bioplastic biomaterial data for vehicle bio-bumper from banana peel waste biomass." Data in brief vol. 8 (2016): 286-94. doi: https://doi.org/10.1016/j.dib.2016.05.029
Sharif Hossain AB, Ibrahim NA, AlEissa MS. Nano-cellulose derived bioplastic biomaterial data for vehicle bio-bumper from banana peel waste biomass. Data Brief. 2016 May 25;8:286-94. doi: 10.1016/j.dib.2016.05.029. eCollection 2016 Sep. PMID: 27331103; PMCID: PMC4906129.
Copy Download .nbib Format: NLM
Tyrosinemia type II: Report of the first four cases in Saudi Arabia.

Annals of Saudi medicine

Al-Essa M, Rashed M, Ozand PT.
PMID: 17344737
Ann Saudi Med. 1998;18(5):466-8. doi: 10.5144/0256-4947.1998.466.

No abstract available.

Cite
Al-Essa M, Rashed M, Ozand PT. Tyrosinemia type II: Report of the first four cases in Saudi Arabia. Ann Saudi Med. 1998;18(5):466-8doi: 10.5144/0256-4947.1998.466.
Al-Essa, M., Rashed, M., & Ozand, P. T. (1998). Tyrosinemia type II: Report of the first four cases in Saudi Arabia. Annals of Saudi medicine, 18(5), 466-8. https://doi.org/10.5144/0256-4947.1998.466
Al-Essa, M, et al. "Tyrosinemia type II: Report of the first four cases in Saudi Arabia." Annals of Saudi medicine vol. 18,5 (1998): 466-8. doi: https://doi.org/10.5144/0256-4947.1998.466
Al-Essa M, Rashed M, Ozand PT. Tyrosinemia type II: Report of the first four cases in Saudi Arabia. Ann Saudi Med. 1998;18(5):466-8. doi: 10.5144/0256-4947.1998.466. PMID: 17344737.
Copy Download .nbib Format: NLM
Wolman's disease: The King Faisal Specialist Hospital and Research Centre experience.

Annals of Saudi medicine

Al Essa M, Nounou R, Sakati N, Le Quesne G, Joshi S, Archibald A, Ozand PT.
PMID: 17341941
Ann Saudi Med. 1998 Mar-Apr;18(2):120-4. doi: 10.5144/0256-4947.1998.120.

BACKGROUND: Wolman's disease is a rare autosomal recessive lysosomal storage disease. A recent review indicates that approximately 50 patients have been reported in the world. Reports of patients from the Arabian peninsula are rare due to lack of awareness...

Cite
Al Essa M, Nounou R, Sakati N, et al. Wolman's disease: The King Faisal Specialist Hospital and Research Centre experience. Ann Saudi Med. 1998;18(2):120-4doi: 10.5144/0256-4947.1998.120.
Al Essa, M., Nounou, R., Sakati, N., Le Quesne, G., Joshi, S., Archibald, A., & Ozand, P. T. (1998). Wolman's disease: The King Faisal Specialist Hospital and Research Centre experience. Annals of Saudi medicine, 18(2), 120-4. https://doi.org/10.5144/0256-4947.1998.120
Al Essa, M, et al. "Wolman's disease: The King Faisal Specialist Hospital and Research Centre experience." Annals of Saudi medicine vol. 18,2 (1998): 120-4. doi: https://doi.org/10.5144/0256-4947.1998.120
Al Essa M, Nounou R, Sakati N, Le Quesne G, Joshi S, Archibald A, Ozand PT. Wolman's disease: The King Faisal Specialist Hospital and Research Centre experience. Ann Saudi Med. 1998 Mar-Apr;18(2):120-4. doi: 10.5144/0256-4947.1998.120. PMID: 17341941.
Copy Download .nbib Format: NLM
Glutaric acidemia type 1: First Saudi patient diagnosed by tandem mass spectrometry-based neonatal screening.

Annals of Saudi medicine

Soufi S, Rashed MS, Al Essa M, Bucknall MP, Refi A, Badaghesh F, Habib HS, Ozand PT.
PMID: 17341951
Ann Saudi Med. 1998 Mar-Apr;18(2):160-3. doi: 10.5144/0256-4947.1998.160.

No abstract available.

Cite
Soufi S, Rashed MS, Al Essa M, et al. Glutaric acidemia type 1: First Saudi patient diagnosed by tandem mass spectrometry-based neonatal screening. Ann Saudi Med. 1998;18(2):160-3doi: 10.5144/0256-4947.1998.160.
Soufi, S., Rashed, M. S., Al Essa, M., Bucknall, M. P., Refi, A., Badaghesh, F., Habib, H. S., & Ozand, P. T. (1998). Glutaric acidemia type 1: First Saudi patient diagnosed by tandem mass spectrometry-based neonatal screening. Annals of Saudi medicine, 18(2), 160-3. https://doi.org/10.5144/0256-4947.1998.160
Soufi, S, et al. "Glutaric acidemia type 1: First Saudi patient diagnosed by tandem mass spectrometry-based neonatal screening." Annals of Saudi medicine vol. 18,2 (1998): 160-3. doi: https://doi.org/10.5144/0256-4947.1998.160
Soufi S, Rashed MS, Al Essa M, Bucknall MP, Refi A, Badaghesh F, Habib HS, Ozand PT. Glutaric acidemia type 1: First Saudi patient diagnosed by tandem mass spectrometry-based neonatal screening. Ann Saudi Med. 1998 Mar-Apr;18(2):160-3. doi: 10.5144/0256-4947.1998.160. PMID: 17341951.
Copy Download .nbib Format: NLM
Child maltreatment prevention strategies: Saudi youth perspectives.

International journal of pediatrics & adolescent medicine

Al-Eissa MA, ElChoueiry N, AlBuhairan F, Saleheen HN, Almuneef MA.
PMID: 30805541
Int J Pediatr Adolesc Med. 2018 Sep;5(3):92-98. doi: 10.1016/j.ijpam.2018.06.002. Epub 2018 Sep 13.

BACKGROUND AND OBJECTIVES: Child maltreatment (CM) is a global problem that has long-term negative outcomes. The objective of this study is to explore the knowledge and perceptions of youth regarding CM prevention.METHODS: The study was conducted in Saudi Arabia...

Cite
Al-Eissa MA, ElChoueiry N, AlBuhairan F, et al. Child maltreatment prevention strategies: Saudi youth perspectives. Int J Pediatr Adolesc Med. 2018;5(3):92-98doi: 10.1016/j.ijpam.2018.06.002.
Al-Eissa, M. A., ElChoueiry, N., AlBuhairan, F., Saleheen, H. N., & Almuneef, M. A. (2018). Child maltreatment prevention strategies: Saudi youth perspectives. International journal of pediatrics & adolescent medicine, 5(3), 92-98. https://doi.org/10.1016/j.ijpam.2018.06.002
Al-Eissa, Majid A, et al. "Child maltreatment prevention strategies: Saudi youth perspectives." International journal of pediatrics & adolescent medicine vol. 5,3 (2018): 92-98. doi: https://doi.org/10.1016/j.ijpam.2018.06.002
Al-Eissa MA, ElChoueiry N, AlBuhairan F, Saleheen HN, Almuneef MA. Child maltreatment prevention strategies: Saudi youth perspectives. Int J Pediatr Adolesc Med. 2018 Sep;5(3):92-98. doi: 10.1016/j.ijpam.2018.06.002. Epub 2018 Sep 13. PMID: 30805541; PMCID: PMC6364574.
Copy Download .nbib Format: NLM
Pregnant women's use and attitude toward herbal, vitamin, and mineral supplements in an academic tertiary care center, Riyadh, Saudi Arabia.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Al Essa M, Alissa A, Alanizi A, Bustami R, Almogbel F, Alzuwayed O, Abo Moti M, Alsadoun N, Alshammari W, Albekairy A, Al Harbi S, Alhokail M, Gramish J.
PMID: 30662317
Saudi Pharm J. 2019 Jan;27(1):138-144. doi: 10.1016/j.jsps.2018.09.007. Epub 2018 Sep 11.

BACKGROUND: Herbal medicine has been widely utilized by pregnant women despite the limited available evidence regarding the safety and efficacy of that practice. The current available studies, from different countries, estimated that the use of herbal medicine during pregnancy...

Cite
Al Essa M, Alissa A, Alanizi A, et al. Pregnant women's use and attitude toward herbal, vitamin, and mineral supplements in an academic tertiary care center, Riyadh, Saudi Arabia. Saudi Pharm J. 2018;27(1):138-144doi: 10.1016/j.jsps.2018.09.007.
Al Essa, M., Alissa, A., Alanizi, A., Bustami, R., Almogbel, F., Alzuwayed, O., Abo Moti, M., Alsadoun, N., Alshammari, W., Albekairy, A., Al Harbi, S., Alhokail, M., & Gramish, J. (2019). Pregnant women's use and attitude toward herbal, vitamin, and mineral supplements in an academic tertiary care center, Riyadh, Saudi Arabia. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 27(1), 138-144. https://doi.org/10.1016/j.jsps.2018.09.007
Al Essa, Mohammed, et al. "Pregnant women's use and attitude toward herbal, vitamin, and mineral supplements in an academic tertiary care center, Riyadh, Saudi Arabia." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 27,1 (2019): 138-144. doi: https://doi.org/10.1016/j.jsps.2018.09.007
Al Essa M, Alissa A, Alanizi A, Bustami R, Almogbel F, Alzuwayed O, Abo Moti M, Alsadoun N, Alshammari W, Albekairy A, Al Harbi S, Alhokail M, Gramish J. Pregnant women's use and attitude toward herbal, vitamin, and mineral supplements in an academic tertiary care center, Riyadh, Saudi Arabia. Saudi Pharm J. 2019 Jan;27(1):138-144. doi: 10.1016/j.jsps.2018.09.007. Epub 2018 Sep 11. PMID: 30662317; PMCID: PMC6323193.
Copy Download .nbib Format: NLM
Knowledge and Attitudes of Saudi Emergency Physicians toward t-PA Use in Stroke.

Neurology research international

Al Khathaami AM, Aloraini H, Almudlej S, Al Issa H, Elshammaa N, Alsolamy S.
PMID: 30364030
Neurol Res Int. 2018 Oct 01;2018:3050278. doi: 10.1155/2018/3050278. eCollection 2018.

BACKGROUND AND OBJECTIVES: Tissue plasminogen activator (t-PA) within 4.5 hours from onset improves outcome in patients with ischemic stroke and has been recommended by several international guidelines. Since its approval in 1996, the debate among emergency physicians continues particularly...

Cite
Al Khathaami AM, Aloraini H, Almudlej S, et al. Knowledge and Attitudes of Saudi Emergency Physicians toward t-PA Use in Stroke. Neurol Res Int. 2018;2018:3050278doi: 10.1155/2018/3050278.
Al Khathaami, A. M., Aloraini, H., Almudlej, S., Al Issa, H., Elshammaa, N., & Alsolamy, S. (2018). Knowledge and Attitudes of Saudi Emergency Physicians toward t-PA Use in Stroke. Neurology research international, 20183050278. https://doi.org/10.1155/2018/3050278
Al Khathaami, Ali M, et al. "Knowledge and Attitudes of Saudi Emergency Physicians toward t-PA Use in Stroke." Neurology research international vol. 2018 (2018): 3050278. doi: https://doi.org/10.1155/2018/3050278
Al Khathaami AM, Aloraini H, Almudlej S, Al Issa H, Elshammaa N, Alsolamy S. Knowledge and Attitudes of Saudi Emergency Physicians toward t-PA Use in Stroke. Neurol Res Int. 2018 Oct 01;2018:3050278. doi: 10.1155/2018/3050278. eCollection 2018. PMID: 30364030; PMCID: PMC6188773.
Copy Download .nbib Format: NLM
Azathioprine Hypersensitivity Syndrome: Two Cases of Febrile Neutrophilic Dermatosis Induced by Azathioprine.

Case reports in dermatology

Aleissa M, Nicol P, Godeau M, Tournier E, de Bellissen F, Robic MA, Livideanu CB, Mazereeuw-Hautier J, Paul C.
PMID: 28203157
Case Rep Dermatol. 2017 Jan 19;9(1):6-11. doi: 10.1159/000454876. eCollection 2017.

BACKGROUND: Azathioprine is an immunosuppressive agent used in the treatment of immune-mediated diseases. Azathioprine hypersensitivity syndrome is a rare adverse reaction occurring a few days to weeks after the administration of azathioprine.CASE 1: A 36-year-old male with ulcerative colitis...

Cite
Aleissa M, Nicol P, Godeau M, et al. Azathioprine Hypersensitivity Syndrome: Two Cases of Febrile Neutrophilic Dermatosis Induced by Azathioprine. Case Rep Dermatol. 2017;9(1):6-11doi: 10.1159/000454876.
Aleissa, M., Nicol, P., Godeau, M., Tournier, E., de Bellissen, F., Robic, M. A., Livideanu, C. B., Mazereeuw-Hautier, J., & Paul, C. (2017). Azathioprine Hypersensitivity Syndrome: Two Cases of Febrile Neutrophilic Dermatosis Induced by Azathioprine. Case reports in dermatology, 9(1), 6-11. https://doi.org/10.1159/000454876
Aleissa, Majed, et al. "Azathioprine Hypersensitivity Syndrome: Two Cases of Febrile Neutrophilic Dermatosis Induced by Azathioprine." Case reports in dermatology vol. 9,1 (2017): 6-11. doi: https://doi.org/10.1159/000454876
Aleissa M, Nicol P, Godeau M, Tournier E, de Bellissen F, Robic MA, Livideanu CB, Mazereeuw-Hautier J, Paul C. Azathioprine Hypersensitivity Syndrome: Two Cases of Febrile Neutrophilic Dermatosis Induced by Azathioprine. Case Rep Dermatol. 2017 Jan 19;9(1):6-11. doi: 10.1159/000454876. eCollection 2017. PMID: 28203157; PMCID: PMC5301102.
Copy Download .nbib Format: NLM
Correlation between Xerostomia index, Clinical Oral Dryness Scale, and ESSPRI with different hyposalivation tests.

Open access rheumatology : research and reviews

Hijjaw O, Alawneh M, Ojjoh K, Abuasbeh H, Alkilany A, Qasem N, Al-Essa M, AlRyalat SA.
PMID: 30655709
Open Access Rheumatol. 2019 Jan 04;11:11-18. doi: 10.2147/OARRR.S188937. eCollection 2019.

BACKGROUND AND OBJECTIVE: Xerostomia is a subjective measure of dry mouth, while hyposalivation is an objective measure of reduced saliva flow rate. In this study, we aim to assess the association between commonly used xerostomia scoring systems, with different...

Cite
Hijjaw O, Alawneh M, Ojjoh K, et al. Correlation between Xerostomia index, Clinical Oral Dryness Scale, and ESSPRI with different hyposalivation tests. Open Access Rheumatol. 2019;11:11-18doi: 10.2147/OARRR.S188937.
Hijjaw, O., Alawneh, M., Ojjoh, K., Abuasbeh, H., Alkilany, A., Qasem, N., Al-Essa, M., & AlRyalat, S. A. (2019). Correlation between Xerostomia index, Clinical Oral Dryness Scale, and ESSPRI with different hyposalivation tests. Open access rheumatology : research and reviews, 1111-18. https://doi.org/10.2147/OARRR.S188937
Hijjaw, Ola, et al. "Correlation between Xerostomia index, Clinical Oral Dryness Scale, and ESSPRI with different hyposalivation tests." Open access rheumatology : research and reviews vol. 11 (2019): 11-18. doi: https://doi.org/10.2147/OARRR.S188937
Hijjaw O, Alawneh M, Ojjoh K, Abuasbeh H, Alkilany A, Qasem N, Al-Essa M, AlRyalat SA. Correlation between Xerostomia index, Clinical Oral Dryness Scale, and ESSPRI with different hyposalivation tests. Open Access Rheumatol. 2019 Jan 04;11:11-18. doi: 10.2147/OARRR.S188937. eCollection 2019. PMID: 30655709; PMCID: PMC6324613.
Copy Download .nbib Format: NLM
Prevalence of metabolic syndrome in dialysis and transplant patients.

Diabetes, metabolic syndrome and obesity : targets and therapy

AlShelleh S, AlAwwa I, Oweis A, AlRyalat SA, Al-Essa M, Saeed I, Alhawari HH, Alzoubi KH.
PMID: 31118720
Diabetes Metab Syndr Obes. 2019 Apr 29;12:575-579. doi: 10.2147/DMSO.S200362. eCollection 2019.

No abstract available.

Cite
AlShelleh S, AlAwwa I, Oweis A, et al. Prevalence of metabolic syndrome in dialysis and transplant patients. Diabetes Metab Syndr Obes. 2019;12:575-579doi: 10.2147/DMSO.S200362.
AlShelleh, S., AlAwwa, I., Oweis, A., AlRyalat, S. A., Al-Essa, M., Saeed, I., Alhawari, H. H., & Alzoubi, K. H. (2019). Prevalence of metabolic syndrome in dialysis and transplant patients. Diabetes, metabolic syndrome and obesity : targets and therapy, 12575-579. https://doi.org/10.2147/DMSO.S200362
AlShelleh, Sameeha, et al. "Prevalence of metabolic syndrome in dialysis and transplant patients." Diabetes, metabolic syndrome and obesity : targets and therapy vol. 12 (2019): 575-579. doi: https://doi.org/10.2147/DMSO.S200362
AlShelleh S, AlAwwa I, Oweis A, AlRyalat SA, Al-Essa M, Saeed I, Alhawari HH, Alzoubi KH. Prevalence of metabolic syndrome in dialysis and transplant patients. Diabetes Metab Syndr Obes. 2019 Apr 29;12:575-579. doi: 10.2147/DMSO.S200362. eCollection 2019. PMID: 31118720; PMCID: PMC6501046.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 162 entries